Phibro Animal Health Corporation $PAHC Shares Sold by LSV Asset Management

LSV Asset Management trimmed its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) by 11.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 179,700 shares of the company’s stock after selling 24,000 shares during the quarter. LSV Asset Management owned 0.44% of Phibro Animal Health worth $6,714,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. 1620 Investment Advisors Inc. boosted its holdings in shares of Phibro Animal Health by 77.4% in the fourth quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company’s stock worth $25,000 after buying an additional 295 shares during the period. Farther Finance Advisors LLC increased its position in shares of Phibro Animal Health by 113.2% in the fourth quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock worth $27,000 after acquiring an additional 386 shares in the last quarter. Hughes Financial Services LLC purchased a new position in shares of Phibro Animal Health in the third quarter worth approximately $40,000. iSAM Funds UK Ltd purchased a new position in shares of Phibro Animal Health in the third quarter worth approximately $61,000. Finally, Advisory Services Network LLC purchased a new position in shares of Phibro Animal Health in the third quarter worth approximately $96,000. 99.34% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently weighed in on PAHC shares. Citigroup dropped their target price on shares of Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating on the stock in a research report on Thursday, May 14th. Zacks Research downgraded shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 21st. Morgan Stanley set a $49.00 target price on shares of Phibro Animal Health in a research report on Friday, February 6th. Wall Street Zen downgraded shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, Weiss Ratings downgraded shares of Phibro Animal Health from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 8th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $38.80.

Phibro Animal Health Stock Performance

PAHC stock opened at $33.68 on Wednesday. The company has a debt-to-equity ratio of 1.97, a quick ratio of 1.26 and a current ratio of 3.17. The stock has a market cap of $1.37 billion, a P/E ratio of 14.45, a P/E/G ratio of 0.50 and a beta of 0.61. The firm has a 50 day simple moving average of $49.66 and a 200 day simple moving average of $45.90. Phibro Animal Health Corporation has a 52 week low of $22.85 and a 52 week high of $60.08.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.72 by $0.04. The business had revenue of $383.54 million during the quarter, compared to analysts’ expectations of $367.02 million. Phibro Animal Health had a net margin of 6.35% and a return on equity of 37.14%. Phibro Animal Health has set its FY 2026 guidance at 2.980-3.100 EPS. Research analysts anticipate that Phibro Animal Health Corporation will post 3.07 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 24th. Investors of record on Wednesday, June 3rd will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Wednesday, June 3rd. Phibro Animal Health’s dividend payout ratio (DPR) is currently 20.60%.

Insider Activity at Phibro Animal Health

In related news, CEO Jack Bendheim sold 4,528 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $48.49, for a total transaction of $219,562.72. Following the completion of the sale, the chief executive officer directly owned 56,152 shares in the company, valued at approximately $2,722,810.48. This trade represents a 7.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 81,968 shares of company stock worth $4,395,532 in the last ninety days. Company insiders own 50.13% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.